Home > Compliance Monitoring > Urine Baselines

How compliant are your patients?

Let AIT help you discover what is really going on with your patients and your practice. Urine baselines provide you with comprehensive compliance information and give you the ability to benchmark your office compliance on a state and national level.

• Offers compliance graphs as an objective way to benchmark compliance without taking away from each practice’s unique approach to treatment.

• Gives you a snapshot of office compliance during a specific period of time.
• Allows for multiple studies throughout the year to help you track the positive impact of AIT’s compliance monitoring services.
• Customizes studies to meet your unique needs and those of your patients.
• Provides you with a categorized report detailing each patient’s frequency and history of compliance testing within your office.
• Provides a quick reference with details on the patient’s prescribed medications as well as any non-prescribed medication or illicit drug found in the patient’s system.
• A recent study showed that physicians identified only 13.9% of patients with chronic pain who were prescribed opioids as manifesting aberrant drug-related behaviors, when actually about 50% had a positive urine drug test result that documented illicit drug use¹. Urine baselines are just one way AIT partners with physicians to identify patient compliance issues in order to improve treatment outcomes.

2010 Non-Compliance Statistics by State² 

For more detailed non-compliance information and statistics, click here.

For more information about urine baselines, AIT Pathways, and other tools for compliance testing, including GuideMed testing protocols and our Patient Adherence Tool, complete the following form and an account executive will contact you as soon as possible. You may also contact our Client Services Department.

References 

1. Granger WJ. "Prescription Drug Abuse: What Price Pain Relief?" Pain Medicine News 7.3 (2009). Web. 4 Jan 2011.
2. Data is based on nearly 200,000 urine samples that were tested by AIT Laboratories in 2010 for the DetectiMed^® Panel and from patients’ medications as identified on their requisition forms.